A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)—United States, 1991–2001 ,

  title={A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)—United States, 1991–2001 ,},
  author={Weigong Zhou and Vitali Pool and Frank Destefano and John K Iskander and Penina Haber and Robert T. Chen},
  journal={Pharmacoepidemiology and Drug Safety},
Post‐licensure experience with a new intranasal inactivated influenza vaccine in Switzerland recently identified an increased risk for Bell's palsy. We reviewed reports in the Vaccine Adverse Event Reporting System (VAERS) to assess if parenteral inactivated influenza vaccines (influenza vaccines) may also increase the risk for Bell's palsy. 

Paper Mentions

Bell’s Palsy and Parenteral Inactivated Influenza Vaccine
A large population based study using the General Practice Research Database was performed to test the hypothesis that there was an increased risk of Bell’s palsy in the three months following parenteral inactivated influenza vaccine. Expand
Bell's palsy and SARS-CoV-2 vaccines
The literature on the association of Bell’s palsy with vaccination, and vaccination for respiratory viruses such as influenza in particular, is reviewed, to consider biological mechanisms that might explain observed associations, and to reconsider statistical and epidemiological evidence from the reported safety data of the SARS-CoV-2 vaccine trials. Expand
Bell's Palsy Cases Following Administration of Influenza A (H1N1) 2009 Monovalent Vaccine Reported to the Vaccine Adverse Event Reporting System (VAERS)
There was no pattern in the demographic and clinical characteristics to suggest an increased risk of Bell's palsy after 2009-H1N1 vaccination, and the higher reporting rate of Bell’s palsy to VAERS following receipt of 2009-N1 vaccine compared to seasonal influenza vaccine may be due to stimulated reporting. Expand
Bell's palsy associated with influenza vaccination: two case reports.
The incidence of Bell's palsy following the administration of an influenza vaccine is low, and patients should be apprised of the possibility of this complication and the benefit of early treatment. Expand
Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.
Adverse event reporting rates have been reasonably constant over time and provide useful information if pandemic vaccine is rapidly distributed and pre-licensure data are limited. Expand
Bell’s Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell’s palsy
The association between vaccine administration and onset of symptomatic Bell’s Palsy may warrant further investigation. Expand
Bell’s palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series
No evidence for an increased incidence of Bell’s palsy following seasonal influenza vaccination overall, nor for monovalent pandemic influenza vaccine in 2009 is found. Expand
Adverse events following immunization: perception and evidence
Currently available vaccines are safe in immunocompetent individuals and there is no evidence to deviate from current immunization schedules. Expand
Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience
The challenge of influenza vaccine safety is to detect new safety concerns that may arise during seasonal campaigns, while preparing vaccine safety systems for the timely detection of adverse events in the setting of a pandemic. Expand
Immunization and Bell's palsy in children: a case-centered analysis.
There is no association between immunization and Bell's palsy in children following immunization with inactivated trivalent influenza vaccine (TIV) and hepatitis B virus (HBV) vaccine. Expand